@article{6c2086e4d0474b00b80c6b4194357f09,
title = "Moving toward precision medicine with lung cancer organoids",
abstract = "In this issue of Cell Reports Medicine, Wang et al.1 generated 160 human lung cancer organoids, primarily from malignant effusions, and tested their responses to clinically used drugs to determine whether the ex vivo organoid responses predicted patient responses.",
author = "James Kim and Minna, {John D.}",
note = "Funding Information: This work is supported by NIH grant R01 CA258684 to J.K. and grants P50 CA070907, CA224065, CA225960, and CA142543 to J.D.M, J.K. is a member of a scientific advisory board for Sanofi and consults for Pulmatrix, Inc. J.D.M. receives royalties from the NCI and UT Southwestern Medical Center for distribution of human tumor cell lines. Funding Information: This work is supported by NIH grant R01 CA258684 to J.K. and grants P50 CA070907 , CA224065 , CA225960 , and CA142543 to J.D.M Publisher Copyright: {\textcopyright} 2023 The Author(s)",
year = "2023",
month = feb,
day = "21",
doi = "10.1016/j.xcrm.2023.100952",
language = "English (US)",
volume = "4",
journal = "Cell Reports Medicine",
issn = "2666-3791",
publisher = "Cell Press",
number = "2",
}